Table 1

Demographics and baseline characteristics in the Full Analysis Set

Overall
(n=26)
Group 1
(n=12)
Group 2
(n=14)
P value
Age, mean (SD), years46.5 (12.7)48.3 (12.3)45.0 (13.2)0.571
Female, %2317290.652
Time since amputation, mean (SD), years7.0 (6.6)6.4 (4.6)7.5 (8.1)0.877
Time since onset of RLP, mean (SD), years7.1 (6.9)5.9 (4.4)8.2 (8.6)0.735
Time since onset of PLP, mean (SD), years7.0 (6.8)6.3 (4.9)7.5 (8.1)0.978
Level of amputation0.021
 Above knee, n (%)15 (58)10 (83)5 (36)
 Below knee, n (%)11 (42)2 (17)9 (64)
Treatment history (% currently in use, % previously in use)
 Opioid medication42, 5042, 5043, 50>0.999
 Non-opioid medications65, 2767, 2564, 29>0.999
 Surface stimulation0, 310, 330, 29>0.999
 Spinal cord stimulation0, 00, 00, 0
 Physical therapy4, 810, 837, 79>0.999
 Acupuncture0, 80, 80, 7>0.999
 Steroid injection0, 150, 80, 210.598
 Botulinum toxin injection0, 00, 00, 0
 Nerve block0, 190, 170, 21>0.999
 Other4, 80, 177, 00.337
  • PLP, phantom limb pain; RLP, residual limb pain.